BD - Earth day 2024

AI Medical Service Inc. Registers Gastric AI Endoscopic Diagnostic Support with Singapore HSA

Wednesday, February 21, 2024

AI MEDICAL SERVICE INC. ("AIM"), a pioneering medical startup, specializes in developing endoscopic artificial intelligence diagnostics. Recently, the company announced a milestone achievement: its artificial intelligence-based device for endoscopic diagnostic support within the stomach successfully passed the initial review and device registration by Singapore regulatory authorities. Branded as the "endoscopic imaging diagnostic support software - gastroAI-model G," this innovative technology can identify gastric lesions and distinguish between neoplastic and non-neoplastic nature.

Gastric cancer stands as the fifth most common cancer globally, affecting over a million people annually, with approximately 770,000 succumbing to the disease. The mortality rate significantly increases as the disease progresses. Early detection is pivotal; the 5-year relative survival rate is around 95% if detected in stage I, but drops to less than 50% if diagnosed in stage III or later. However, early gastric cancer is challenging to detect, with 4.5% to 25.8% of cases being missed.

Countries like Japan and South Korea conduct routine endoscopic gastric cancer screenings, but such practices are not widespread in Singapore and other regions, making early detection more challenging. AIM's efforts to raise awareness of the value of endoscopic AI in clinical practice in Singapore are notable. The company's commitment is evident in the years spent navigating regulatory reviews and obtaining device registration in Singapore.

The "endoscopic imaging diagnosis support software - gastroAI-model G" provides a diagnostic support system for determining the nature of gastric lesions promptly. By analyzing static endoscopic images acquired during the procedure, it offers near-instant feedback to physicians, potentially revolutionizing gastric cancer screening and diagnosis.

AIM's achievement marks a significant step forward in medical technology, promising improved patient outcomes and better healthcare practices. Continued efforts in research, development, and deployment of such innovative medical technologies will undoubtedly contribute to advancing patient care globally.